Burzynski Research Institute, Inc. (BZYR) Research

The Burzynski Research Institute, Inc. primarily focuses on the exploration and development of antineoplaston medications designed for cancer treatment. Beyond its research efforts, the company is actively engaged in the manufacturing, promotion, and distribution of specialized medical chemical compounds. These unique substances, known commercially as Antineoplastons, are comprised of peptides that inhibit growth, alongside amino acid derivatives and various organic acids. The institute also extends its expertise by offering consulting services. Founded in Houston, Texas, in 1977, the organization has its principal operations in that city.

Open Burzynski Research Institute, Inc. (BZYR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.